Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prudentia Capital is an independent French private equity firm that specializes in supporting the growth and transformation of small and medium-sized enterprises (SMEs) across Europe, with a notable focus on the healthcare and life sciences sectors. The firm provides strategic guidance and capital for various scenarios, including organic growth, acquisitions, and industrial reorganizations, typically targeting companies with revenues between €20 million and €250 million. In the healthcare space, Prudentia Capital has invested in segments such as medical technology, specialized healthcare services, and pharmaceutical distribution. Their investment approach involves active partnership with management teams to drive operational improvements and international expansion. By leveraging deep industry expertise and a hands-on operational model, the firm aims to create long-term value for its portfolio companies and investors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prudentia Capital.